According to estimates, the non-vascular stents industry will be valued US$ 1.21 billion in 2022 and is projected to rise at a 4.5% compound annual growth rate (CAGR) until 2032, when sales are anticipated to reach US$ 1.9 billion. The increasing demand for less invasive procedures is projected to fuel growth in the non-vascular stent …